Novartis CEO: Inclisiran Could Be Largest Medicine In NHS History
Pact To Make As-Yet-Unapproved Drug Widely Available
The Swiss major has been enthusing about its population-based agreement in the UK for the investigational gene silencing cholesterol lower and plans for similar schemes in other countries.
